| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Which Networking Group For You? |
|
Useful Advices - Which Networking Group For You?
Deciding the best one or two networking groups to join is crucial to building your referral network. Many people make the m According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product istake of thinking they should belong to every possible Chamber of Commerce, but then wonder why there is no return on the f ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in inancial investment. The statement above is one reason for the lack of ROI. Those who think only of budget concerns when d lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. eciding to join an organization are thinking of only one third of the equation. The second and third components are time an here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe d commitment. Someone who belongs to five chambers is only able to attend a few events each month per chamber. Their effor d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t is diluted. They typically are time-extended and arrive late for many meetings. The also tend to leave a little early. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc They are doing themselves a huge disservice. We have been taught that relationship building and trust are two factors that easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi create strong referral partnerships. When someone constantly arrives late, they are limiting the opportunity to meet new pe nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ople or connect with familiar people. Same thing for leaving early. The savvy networker brings her calendar with her to ev and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ents and then uses the time after the event to immediately schedule one-to-one appointments with those in attendance. Those ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi leaving early miss that opportunity. Another common mistake is joining several strong contact network groups. The definiti ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a on of a strong contact group is an organization that limits their membership to one person per profession. The members meet dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod for the reason of developing relationships in order to be comfortable sharing referral business with others in their group. cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin Sounds good, right? It is good, but when someone joins more than one of these groups, their loyalties are divided. How d tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen oes this dual member determine which member of which group to give a referral to when each member represents the same catego t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ry. There are bound to be hard feelings. People who make this mistake may have an attitude of scarcity. They feel they do ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust n’t have enough, so they are going to try to take it all. Members of each group who become aware of such a situation and th y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products e lack of commitment, wonder about the dual member’s integrity. Instead of getting it all, they may get less or none. Not . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de what they had planned. Carefully choose the appropriate groups for you. Visit twice, talk to other members of the prospect elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ive group and understand your own goals before selection. The right decision can make a huge difference in your bottom line tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:New Grads Don't Have to Settle for Bad Jobs! Real Estate Letters; Low Cost, High Profitability
|